Advertisement
Home »

Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trial.

Feb 19, 2024

ABOUT THE EXPERTS

  • Matthew Machin

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Imperial Vascular Unit, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK.

    Sarah Whittley

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    John Norrie

    Edinburgh Clinical Trials Unit, University of Edinburgh, Level 2, NINE Edinburgh BioQuarter, The University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.

    Laura Burgess

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Beverley J Hunt

    Thrombosis and Haemophilia Centre, Guy’s and St Thomas’ Foundation Trust, London, UK.

    Layla Bolton

    Imperial Vascular Unit, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK.

    Joseph Shalhoub

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Imperial Vascular Unit, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK.

    Tamara Everington

    Hampshire Hospitals NHS Foundation Trust, Winchester, Hampshire, UK.

    Manjit Gohel

    Cambridge Vascular Unit, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

    Mark S Whiteley

    The Whiteley Clinic, London, UK.

    Steven Rogers

    Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

    Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Manchester, UK.

    Sarah Onida

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Imperial Vascular Unit, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK.

    Benedict Turner

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Sandip Nandhra

    Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

    Rebecca Lawton

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Annya Stephens-Boal

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Carolyn Singer

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Joanne Dunbar

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK.

    Daniel Carradice

    Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK.

    A H Davies

    Section of Vascular Surgery, Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK a.h.davies@imperial.ac.uk.

    Imperial Vascular Unit, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement